ICU-Associated Acinetobacter baumannii Colonisation/Infection in a High HIV-Prevalence Resource-Poor Setting

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Ntusi, Ntobeko B A ^a   Badri, Motasim ^a   Khalfey, Hoosain ^a   Whitelaw, Andrew ^a   Oliver, Stephen ^a   Piercy, Jenna ^a   Raine, Richard ^a   Joubert, Ivan ^a   Dheda, Keertan ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AFRICA; ANTIBIOTIC SENSITIVITY; APACHE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BLOOD CULTURE; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; SEPSIS; SURGICAL APPROACH;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; CROSS INFECTION; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; PATIENT ADMISSION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

ACINETOBACTER BAUMANNII; NEGIBACTERIA;

EID: 84871662883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052452     Document Type: Article

References (25)

1. Leung WS, Chu CM, Tsang KY, Lo FH, lo KF, et al. (2006) Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 129: 102-109.
2. Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, et al. (2002) Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 40: 685-686.
3. Jones RN, (2003) Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin Respir Crit Care Med 24: 121-134.
4. Potgieter PD, Linton DM, Oliver S, Forder AA, (1987) Nosocomial infections in a respiratory intensive care unit. Crit Care Med 15: 495-498.
5. Patterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, et al. (2004) International prospective study of Klebsiella pneumoniae bacteraemia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 140: 26-32.
6. del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, et al. (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk factors for colonisation and infection. Clin Microbiol Infect 11: 540-546.
7. Falagas ME, Karveli EA, (2007) The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect 13: 117-119.
8. Joly-Guillou ML, (2005) Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 11: 868-873.
9. Gaynes R, Edwards JR, National Nosocomial Infection Survellance System, (2005) Overview of nosocomial infections caused by Gram-negative bacilli. Clin Infect Dis 41: 848-854.
10. Playford EG, Craig JC, Iredell JR, (2007) Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 65: 204-211.
11. Webster CA, Towner KJ, Saunders HH, Crewe-Brown HH, Humphreys H, (1999) Molecular and antibiogram relationships of Acinetobacter isolates from two contrasting hospitals in the United Kingdom and South Africa. Eur J Microbiol Infect Dis 18: 595-598.
12. Gounden R, Bamford C, van Zyl Smit R, Cohen K, Maartens G, (2009) Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections. BMC Infect Dis 9: 26.
13. UNAIDS/World Health Organisation (2009) Report on the global HIV/AIDS epidemic 2009. Available: http://www.unaids.org/en/regionscountries/countries/southafrica/. Accessed 2012 Aug 3.
14. Zapor MJ, Moran KA, (2005) Infectious diseases during war-time. Curr Opinion Infect Dis 18: 395-399.
15. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, et al. (1995) The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA 274: 639-644.
16. Paul M, Weinberger M, Siegman-Igra Y, Lazarovitch T, Ostfeld I, et al. (2005) Acinetobacter baumannii: Emergence and spread in Israeli hospitals 1997-2002. J Hosp Infect 60: 256-260.
17. Diekema DJ, Pfaller MA, Jones RN, Doern GV, Kugler KC, et al. (2000) Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infection is the USA, Canada and Latin America. Int J Antimicrob Agents 13: 257-271.
18. Trottier V, Namias N, Pust DG, Nuwayhid Z, Manning R, et al. (2007) Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect 8: 437-443.
19. Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, et al. (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalisation. Emerging Infect Dis 13: 97-103.
20. Daniels TL, Deppen S, Arbogast PG, Griffin MR, Schaffner W, et al. (2008) Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care patients. Infect Control Hosp Epidemiol 29: 1080-1083.
21. Falagas ME, Bliziotis IA, Siempos II, (2006) Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 10: 793-800.
22. Agarwal R, Gupta D, Ray P, Aggarwal AN, Jindal SK, (2006) Epidemiology, risk factors and outcome of nosocomial infections in a Respiratory Intensive Care Unit in North India. J Infect 53: 98-105.
23. Chen CH, Lin LC, Chang YJ, Huang CC, Liu CE, et al. (2003) Analysis of prognostic factors in 95 patients with Acinetobacter baumannii bacteremia. Infection 31: 331-335.
24. Perez F, Hujer AM, Hujer KM, decker BK, Rather PN, et al. (2007) Global challenge of multi-drug resistant Acinetobacter baumanni. Antimicrob Agents Chemother 51: 3471-3484.
25. Manfredi R, Nanetti A, Valentini R, Chiodo F, (2001) Acinetobacter infections in patients with human immunodeficiency virus infections: Microbiological and clinical epidemiology. Chemotherapy 47: 19-28.